Omeros (OMER) FCF Margin Growth (1y) (2011 - 2022)
Omeros (OMER) FCF Margin Growth (1y) (2011 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -9,669.00 |
| Mar 31, 2022 | -2,598.00 |
| Dec 31, 2021 | 19,602.00 |
| Sep 30, 2021 | 5,488.00 |
| Jun 30, 2021 | 18,291.00 |
| Mar 31, 2021 | -15,207.00 |
| Dec 31, 2020 | -10,421.00 |
| Sep 30, 2020 | -10,876.00 |
| Jun 30, 2020 | -21,657.00 |
| Mar 31, 2020 | 2,117.00 |
| Dec 31, 2019 | 4,350.00 |
| Sep 30, 2019 | 77,680.00 |
| Jun 30, 2019 | 181,757.00 |
| Mar 31, 2019 | 66,257.00 |
| Dec 31, 2018 | -8,209.00 |
| Sep 30, 2018 | -75,028.00 |
| Jun 30, 2018 | -183,095.00 |
| Mar 31, 2018 | -61,864.00 |
| Dec 31, 2017 | 5,423.00 |
| Sep 30, 2017 | 4,792.00 |